-
SILICON VALLEY: Indian-origin executive named CEO of Microsoft Gaming - March 5, 2026
-
WASHINGTON: Indian-American lawyer at center of Trump’s biggest legal setback - March 4, 2026
-
TEXAS: ’15 of my cousins came here on H-1B’ - March 3, 2026
-
NEW YORK: Indian-origin doctor shares mother’s immigrant success journey in US - March 2, 2026
-
ARIZONA: Indian-origin scientist wins Arizona State University’s top Science Prize - March 1, 2026
-
WASHINGTON: Balaji Krishnamoorthy becoming Uber CFO amid ongoing visa row - February 28, 2026
-
LUCKNOW: Prime Minister Narendra Modi on HCL-Foxconn chip facility in UP - February 27, 2026
-
WASHINGTON: 55% Indian Americans Disapprove Of Trump’s India Policies: Survey - February 26, 2026
-
WASHINGTON: Trump Praises Indian American Harmeet Dhillon Amid Harvard Case - February 26, 2026
-
MUMBAI: Ranbir Kapoor to set up new RK Studios - February 25, 2026
BERLIN: Metabolic Syndrome Linked To Cardiovascular Problems In Adults With Kidney Disease: Study
BERLIN: The findings of the study were
published in the ‘Journal of Internal Medicine’.
A new
study has uncovered a high prevalence of metabolic syndrome in adults with
moderate chronic kidney disease, and found that metabolic syndrome increases
their risk of premature death and cardiovascular problems.
The
findings of the study were published in the ‘Journal of Internal Medicine’.
Among
5,110 adults in Germany who had chronic kidney disease, 64.3 per cent also had
metabolic syndrome.
During
6.5 years of follow-up, 605 patients died and 650 experienced major
cardiovascular events (such as heart attacks and strokes). Patients with
metabolic syndrome had a 26 per cent higher risk of dying and a 48 per cent
higher risk of experiencing cardiovascular events.
The risk
increased steadily with a growing number of metabolic syndrome components, such
as increased waist circumference, blood sugar levels, triglycerides, and blood
pressure, and decreased HDL cholesterol.
“Although
our study uncovered a shockingly high frequency of metabolic syndrome in this
high-risk patient group, there’s a motivating message for our patients: each
metabolic syndrome component avoided might considerably decrease the risk for a
cardiovascular endpoint or premature death,” said senior author Florian
Kronenberg, MD, of the Medical University of Innsbruck, in Austria.



